Bayer sues Cipla for infringement of its Nexavar patent – C.S.(O.S.) No. 523 of 2010 before the High Court of Delhi
Bayer Corporation has recently launched Round II in its ‘epic’ battle against Cipla over the manufacture and sale of its patented drug ‘Nexavar’ (sorafenib), which has been approved to treat kidney and liver cancer. The Bayer has claimed that by launching a generic version of the drug, Cipla has infringed on its Indian patent no. 215758. Unfortunately the IPIRS system on the Patent Office website has failed to display any information on this patent. The first hearing of the present […]